Treatment of toenail onychomycosis with
2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream
-
T. A. Syed1
1 Department of Dermatology, University of California, San
Francisco, USA ,
- Z. A. Qureshi2
2 University of the Punjab, Lahore, Pakistan
,
- S. M. Ali3
3 Shan Hospital, Gulshan Iqbal, Karachi, Pakistan
,
- S Ahmad4
4 Komvux College, Borås, Sweden and
- S. A. Ahmad5
5 Windsor High School, Windsor, CA, USA
-
1 Department of
Dermatology, University of California, San Francisco, USA
-
2 University of the Punjab,
Lahore, Pakistan
-
3 Shan Hospital, Gulshan
Iqbal, Karachi, Pakistan
-
4 Komvux College, Borås,
Sweden
-
5 Windsor High School,
Windsor, CA, USA
To cite this article: T. A. Syed,
Z. A. Qureshi, S. M. Ali, S Ahmad, S. A. Ahmad (1999)
Treatment of toenail onychomycosis with 2% butenafine and 5%
Melaleuca alternifolia (tea tree) oil in cream
Tropical Medicine & International Health 4 (4), 284–287.
doi:10.1046/j.1365-3156.1999.00396.x
The prevalence of onychomycosis, a superficial
fungal infection that destroys the entire nail unit, is rising, with
no satisfactory cure. The objective of this randomized,
double-blind, placebo-controlled study was to examine the clinical
efficacy and tolerability of 2% butenafine hydrochloride and 5%Melaleuca
alternifolia oil incorporated in a cream to manage toenail
onychomycosis in a cohort. Sixty outpatients (39 m, 21 f) aged 18–80
years (mean 29.6) with 6–36 months duration of disease were
randomized to two groups (40 and 20), active and placebo. After 16
weeks, 80% of patients using medicated cream were cured, as opposed
to none in the placebo group. Four patients in the active treatment
group experienced subjective mild inflammation without discontinuing
treatment. During follow-up, no relapse occurred in cured patients
and no improvement was seen in medication-resistant and placebo
participants.
Read More
This article is cited by:
- Justin J. Finch & Erin M. Warshaw. (2007) Toenail
onychomycosis: current and future treatment options.
Dermatologic Therapy 20:1, 31–46
- Parker Magin, Jon Adams. (2007) Complementary and
alternative medicines: use in skin diseases. Expert Review of
Dermatology 2:1, 41
- Jeffrey D. Lauten, Linda Boyd, M. Blair Hanson, Dana Lillie,
Christina Gullion, Theresa E. Madden. (2005) A clinical study:
melaleuca, manuka, calendula and green tea mouth rinse.
Phytotherapy Research 19:11, 951
- Karen W. Martin and E. Ernst. (2004) Herbal medicines for
treatment of fungal infections: a systematic review of
controlled clinical trials. Phytomedizin zur Behandlung von
Pilzinfektionen: Übersicht und Bewertung kontrollierter
klinischer Studien. Mycoses 47:3-4,
87–92
- Eran Ben-Arye, M. Frenkel, M. Ziv. (2004) An Approach to
Teaching Dermatologists About Complementary Medicine. The
Journal of Alternative and Complementary Medicine 10:5,
899
- B. Oliva, E. Piccirilli, T. Ceddia, E. Pontieri, P. Aureli
and A.M. Ferrini. (2003) Antimycotic activity of Melaleuca
alternifolia essential oil and its major components. Letters
in Applied Microbiology 37:2,
185–187
- Philip Fleckman. (2002) Onychomycosis: diagnosis and topical
therapy. Dermatologic Therapy 15:2,
71–77
- Edzard Ernst, Max H. Pittler, Clare Stevinson. (2002)
Complementary/Alternative Medicine in Dermatology. American
Journal of Clinical Dermatology 3:5,
341
- Dani??le Debruyne, Antoine Coquerel. (2001) Pharmacokinetics
of Antifungal Agents in Onychomycoses. Clinical
Pharmacokinetics 40:6, 441
- D. P. Bruynzeel. (1999) Letter to the Editors. Tropical
Medicine & International Health 4:9,
630–630

|